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Background
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Background of the International Influenza Capacity Review Tool
The CDC-APHL International Influenza Laboratory Capacity Review Tool (IILCRT) is a data gathering tool to assess 
laboratory capabilities and capacities, with an emphasis on influenza diagnostics. The information collected from 
the tool can be used to identify a laboratory’s strengths and challenges. The capacity review with the IILCRT will 
be conducted in the laboratory to assess a wide variety of laboratory aspects. The tool consists of nine modular 
sections which include
n Laboratory Contact Information
n General Laboratory
n Specimen Handling, Collection, and Reporting
n Virology Laboratory
n Molecular Biology Laboratory
n Laboratory Safety and Biosafety 
n Quality Assurance / Quality Control
n Equipment
n Training 
The modular design of the tool allows for each of the sections described above to be administered independently, 
and/or by multiple persons if teams are completing the review. The person(s) performing the capacity review, have 
significant experience in virology (specifically influenza), molecular biology, and influenza diagnostics. In addition, 
the individual(s) performing the capacity review have experience training laboratory staff with the CDC Human 
Influenza Virus Real-Time RT-PCR Detection and Characterization assays. 
Laboratory Contact 
Information




1 Name of Laboratory
2 Which WHO region is the laboratory located? AFR q	 WPR q	 AMR q	 SEAR q  EUR q EMR q
5 Which international funding/partner organizations is the laboratory affiliated with (check all that apply)?
Pasteur q
PAHO q
6 Shipping Address (If different from mailing address)  ___________________________________________________________________________
 _________________________________________________________________________________________________________________________
3 Is the laboratory a WHO National Influenza Center (NIC)? q	Yes q	No q	Do not Know/not sure
3a If No, has the laboratory applied to become a NIC? q	Yes q	No q	Do not Know/not sure




PATH Global Health q
World Bank q












Alternate Email (yahoo, gmail, etc.)
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7 Contact within Ministry of Health
8 Laboratory Director
9 Laboratory Supervisor
Does the contact within the MoH speak English?
If Yes, conversational English
If Yes, scientific English
If Yes, fluent English






Does the Influenza Laboratory Director speak English?
If Yes, conversational English
If Yes, scientific English
If Yes, fluent English
Other spoken languages (please specify)?
Does the Influenza Laboratory Director speak English?
If Yes, conversational English
If Yes, scientific English
If Yes, fluent English











Name __________________________________   Phone ___________________________   Email ______________________________________
Name __________________________________   Phone ___________________________   Email ______________________________________
Name __________________________________   Phone ___________________________   Email ______________________________________
Laboratory Contact Information
International Influenza Laboratory Capacity Review Tool8
Laboratory Contact Information
10 Influenza Laboratory Supervisor (if different from above)
11 Evaluator
12 General Comments/Notes: 




Does the Influenza Laboratory Supervisor speak English?
If Yes, conversational English
If Yes, scientific English
If Yes, fluent English
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General Laboratory
1 What is the laboratory’s affiliation/designation?
2 What is the primary function of the laboratory? q	Public Health Surveillance q	National Influenza Center q	Research 
 q	Diagnostic/Clinical q	Clinical 
  q	Other (please specify) _________________________________________________________
3 What surveillance activities does the laboratory participate in (check all that apply)?
6 How many days per year is the laboratory closed for holidays?
5  M T W Th F Sa Su
 Which days does the laboratory normally operate? ___ ___ ___ ___ ___ ___ ___ 
 How many hours per day does the laboratory normally operate? ___ ___ ___ ___ ___ ___ ___ 
4 What infectious disease testing services does the laboratory provide (check all the apply)? 
q	Ministry of Health q	University Laboratory	 q	Other (please specify) ______________________________________
q	National Laboratory q	Hospital Laboratory 
q	Influenza q	HIV	 q	Respiratory Viruses (Other then Influenza)	 q	Other (please specify) ____________________________
q	0-5 days q	5-10 days	 q	More than 10 days
q	Influenza q	HIV	 q	Foodborne	 q	GI 
q	STD q	TB	 q	Respiratory Viruses	 q	Other (please specify) ____________________________




7 Are there specific months where the laboratory is closed for significant time due to other activities? q	Yes q	No
7a If Yes, please specify which one(s):
8  How many influenza laboratory staff are:  Full-time __________  Part-time __________
11  Please describe the duties of the influenza laboratory staff including:
10 Are laboratory staff cross-trained to perform molecular biology and virology?
9 How many laboratory staff do you have trained to: Full-time Half-time
 Perform influenza virology?  _______   _______
Perform influenza molecular biology?  _______   _______
q	Yes, all staff q	Yes, only select staff members  q	No  q	Don’t know/not sure
Name Title Duties
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General Laboratory
12 On average, how many hours per week do influenza laboratory staff work on other activities besides influenza testing? _________
13 Does the laboratory perform virus isolation?  q	Yes q	No
13a If no, why? ___________________________________________________________________________________________________________________
16 Does the laboratory perform any influenza testing from non-human specimens? q	Yes q	No
 If yes, please describe: ________________________________________________________________________________________________________
14 Does the laboratory perform PCR?  q	Yes q	No
14a If no, why? ___________________________________________________________________________________________________________________
15  Approximately how many influenza specimens does the laboratory receive for diagnostic testing per week? __________________________
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General Laboratory
17 Does the laboratory participate in External Quality Assessment Programs? q	Yes   q	No 
17a How many panels did your laboratory complete in the past year? _______________________________________
  Date Score
17b If yes, please provide score(s):  ________  ________
   ________  ________
   ________  ________
18 Is there a responsible official for receiving specimens:
Time of Day Yes No Don’t know/Not sure If yes, title of the  
responsible officer
If no, who receives 
specimens?
During Normal Operating Hours
After Normal Operating Hours
 
19 Does the laboratory have security measures in place?  q	Yes   q	No
19a If yes, what are these measures (check all that apply)?
 q	Electronic surveillance (cameras) q	ID badges
 q	Manned surveillance  q	Require sign-in of visitors
 q	Electronic security system q	Other (please specify)__________________________
 q	Front door chain locks
20 Does the laboratory have a written biosecurity plan? q	Yes q	No
20a If no, would you be interested in assistance developing one? q	Yes q	No
**Please provide most recent documentation
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General Laboratory
21 Does the laboratory have biosecurity measures in place (i.e. to prevent internal theft)?  q	Yes   q	No
21a If yes, what are these biosecurity measures (check all that apply)?
 q	ID badges q	Cameras
 q	Freezer locks q	Restricted access to laboratories (i.e.BSL 3)
 q	Restricted access to buildings q	Other (please specify)__________________________
22 Does the laboratory have facilities that maintain and care for animals?  q	Yes   q	No 





23 Does the laboratory appear to be structurally sound (no missing windows, doors, etc.)? q	Yes q	No
24 Please indicate the condition of the following in the laboratory: 




25 Does laboratory equipment appear to be placed appropriately given any structural limitations? q	Yes q	No
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General Laboratory
26 In an average week, please indicate the percentage of availability for the following utilities:
Less then 10% 10-50% 50-99% 100%
Electricity
Water
26a Is the available electrical capacity sufficient to power all equipment?       q	Yes   q	No  
27 Does the laboratory have an emergency generator/power supply?      q	Yes   q	No  
27a If yes, do you routinely check its operational status?        q	Yes   q	No  
28 Are critical equipment (PCR machines, freezers, etc.) connected to UPS battery backups? q	Yes   q	No  
28a If yes, do you routinely check its operational status?   q	Yes   q	No  
28b If yes, please indicate voltage capacity: 
 q	220V 
  q	110V
  q	Do not know 
29 Is the laboratory supported by maintenance staff? q	Yes   q	No  
29a If yes, what type of staff (check all that apply): q	Plumber q	Electrician q	Mechanical 
 q	Other (please specify) ______________________________________________________________________________
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Laboratory Response
30 Has the laboratory obtained information concerning the WHO International Health Regulations?      q	Yes   q	No   
30a Does your laboratory have contact information for the Ministry of Health’s IHR focal point? q	Yes   q	No  
30b If yes, what is the contact process? ____________________________________________________
31 Does the laboratory have a crisis plan that can be instituted during an emergency (e.g. national disaster, pandemic)? 
q	Yes   q	No   
31a  If no, are you interested in developing one? q	Yes   q	No
32 Is there a 24 hour, 7 day emergency contact, in case of critical equipment failure or disease outbreaks? 
q	Yes   q	No   
32a If yes, what is their job title? _______________________________________
33 Is the laboratory part of any committee related to public health event management?     q	Yes   q	No   
34 Is the laboratory part of a working group for influenza outbreak investigation?     q	Yes   q	No   
35 Did you participate in any influenza field or outbreak investigations during the past year?     q	Yes   q	No   
General Laboratory
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36 Please provide a brief description of the laboratory’s algorithm for culturing specimens. 
*Please attach a schematic outline of the laboratory’s algorithm
  
 _________________________________________________________________________________________________________  
 _________________________________________________________________________________________________________
 Is the laboratory’s algorithm acceptable?  q	Recommendation   q	Acceptable
37 What are the top three parameters for altering the seasonal influenza algorithm? 
1. __________________________________________________________________________________________________________________________  
2. __________________________________________________________________________________________________________________________  
3. __________________________________________________________________________________________________________________________
38 Please provide a brief description of the laboratory’s protocol/algorithm for the unsubtypable influenza A specimens.  
*Please attach a schematic outline of the laboratory’s algorithm
  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
 Is the laboratory’s protocol/algorithm acceptable?  q	Recommendation   q	Acceptable
Influenza Testing Algorithm
General Laboratory
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General Laboratory
39 Does the laboratory have a written plan to address influenza surge capacity activities? q	Yes   q	No  
 If yes, briefly describe: ________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
39a If no, is the laboratory interested in assistance for developing one? q	Yes   q	No 
40 General Comments/Notes: ____________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
Specimen Handling, 
Collecting, and Reporting
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Specimen Handling, Collecting, and Reporting
1 Does the laboratory have written procedures for influenza specimen:
 Collection? q	Yes q	No  Logging? q	Yes q	No Shipping? q	Yes q	No 
 Transport? q	Yes q	No  Processing? q	Yes q	No
 Labeling? q	Yes q	No  Storage? q	Yes q	No
1a What is the laboratory’s policy for shipping infectious substances to WHO, NIC, or other reference laboratories? ________________________  
 ____________________________________________________________________________________________________________________________
 Is the laboratory’s policy for shipping influenza specimens acceptable?  q	Recommendation   q	Acceptable
2 What type of Viral Transport Medium (VTM) is used?
 q	WHO VTM q	Universal Transport medium
 q	Commercial VTM q	Other VTM (please describe)__________________________
3 What types of influenza specimens does the laboratory accept (check all that apply)?
 q	Nasopharyngeal swabs q	Throat swabs
 q	Nasopharyngeal washes q	Dual nasopharyngeal swabs/ throat swabs
 q	Nasopharyngeal aspirates q	Serum
 q	Nasal swabs q	Other (please describe)__________________________
4 Is an influenza like illness or severe acute respiratory infection case definition used in selecting patients for specimen collection? q	Yes   q	No 
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Specimen Handling, Collecting, and Reporting
5 Who sends influenza specimens to your laboratory (check all that apply)? 
 q	Sentinel providers q	Clinical laboratories
 q	Out reach clinics q	Physician offices
 q	Hospital facilities q	Other (please describe)__________________________
6 How are influenza specimens triaged (check all that apply)? 
 q	All tested q	Subset are tested q	Other (please specify)__________________________
7 Please describe the quality control measures done to make sure the cold chain was maintained. ______________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
Influenza Specimen Receiving  
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Specimen Handling, Collecting, and Reporting
8 How are influenza specimens stored at the sentinel surveillance sites? 
Cold Storage
Normal Hours After Hours
Y/N How Long? How Long?
Refrigeration (2ºC to 8ºC)
Freezer (< -20 ºC)
Freezer ( -70ºC to -80ºC)
Other (please specify)
 Is the storage of influenza specimens at sentinel surveillance sites acceptable?  q	Recommendation   q	Acceptable
8a How are influenza specimens stored prior to laboratory testing?
Cold Storage
Normal Hours After Hours
Y/N How Long? How Long?
Refrigeration (2ºC to 8ºC)
Freezer (< -20 ºC)
Freezer ( -70ºC to -80ºC)
Other (please specify)
 Is the storage of influenza specimens prior to laboratory testing acceptable?  q	Recommendation   q	Acceptable
9 Is there a designated area within influenza for receiving specimens? q	Yes   q	No 





Delay in sample delivery?
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Specimen Handling, Collecting, and Reporting
11 Does the laboratory provide a unique identifier for all influenza specimens? q	Yes   q	No   
12 Are influenza specimens aliquoted before being frozen? q	Yes   q	No   
13 Does the laboratory have written criteria for influenza specimen rejection? q	Yes   q	No   
13a If yes, please specify: _________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
14 What original clinical specimens does the laboratory retain for at least a year (check all that apply):
 q	All specimens q	Specimens testing both positive/negative
 q	Only specimens testing positive q	All inconclusive specimens
 q	Only specimens testing negative
14a If influenza specimens cannot be retained, why? _________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
 Is the retention of specimens acceptable?  q	Recommendation   q	Acceptable
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Influenza Specimen Reporting
15 Please indicate who receives your laboratory’s specimen results:




Turn around time 
from receipt of speci-
men (e.g. <24 hrs, 





Ministry of Health 
Specimen 
Submitter 
Other (please specify): ______________________________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________
 Is the laboratory’s reporting acceptable?  q	Recommendation   q	Acceptable
16 Does the laboratory have reliable connectivity to report out results (cell phones, landlines, internet)? q	Yes   q	No  
17 How often are summary reports generated?
 q	Daily  q	Weekly q	Monthly q	Other (please specify) _______________________________________________
Specimen Handling, Collecting, and Reporting
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Specimen Handling, Collecting, and Reporting
18 Does the laboratory use standardized forms to report results? q	Yes   q	No   
 *Please provide a copy of the laboratory’s standard reporting form
19 Does the laboratory staff know what the reporting requirements are under the International Health Regulations (IHR)?  
q	Yes   q	No 
20 Do test results undergo internal review prior to reporting out? q	Yes    q	No   q	Sometimes  
20a If yes or sometimes, briefly describe the internal review process. ___________________________________________________________________  
 ____________________________________________________________________________________________________________________________
21 Is there a written policy for rapid notification of reportable influenza cases? q	Yes   q	No   
21a If yes, please describe: _______________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
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Influenza Specimen Records
22 Does your laboratory maintain records of reported results?  q	Yes   q	No   
22a If yes, how long? _____________________________________________________________________________________________________________
23 What methods are used to archive reported results? ______________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
23a If archived electronically, how are the records backed up? _________________________________________________________________________
24 Is there restricted access to archived records?  q	Yes   q	No   
24a If yes, who has access? _______________________________________________________________________________________________________  
25 How many times a year are virus isolates or rt-PCR positive specimens sent to WHO (collaborating center  or NIC)? _____________________
25a Which WHO collaborating center does the laboratory send isolates or RNA postitive specimens to?  ___________________________________  
*Please provide additional information regarding specimen shipping in the table at the end of this section.
 Is the laboratory’s shipping frequency acceptable?  q	Recommendation   q	Acceptable 
Influenza Specimen Shipping 
Specimen Handling, Collecting, and Reporting
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Specimen Handling, Collecting, and Reporting
26 Are influenza specimens sent for:
26a Confirmation? q	Yes   q	No 
 If yes, how often are batches sent? _____________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
26b Further characterization? q	Yes   q	No 
 If yes, how often are batches sent? _____________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
27 How does the laboratory track influenza specimens sent to reference laboratories? 
 q	Lab information management system (LIMS) q	Other (please describe) ____________________________________
 q	Software programs installed on computers (i.e. Microsoft Excel) 
 q	Notebook / binder
28 How are isolates chosen for shipping to WHO CC (e.g. age, geographically, etc)? ____________________________________________________  
 ____________________________________________________________________________________________________________________________
 Is the selection of isolates acceptable?  q	Recommendation   q	Acceptable
29 What shipper(s) are located in country? _________________________________________________________________________________________
29a Which vendor is the preferred shipper (e.g. World Courier)? _______________________________________________________________________
29b Does the shipper perform packaging (e.g.. World Courier)?   q	Yes   q	No 
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Specimen Handling, Collecting, and Reporting
30 Does the laboratory experience any problems or difficulties with customs? q	Yes   q	No  
30a If yes, please explain: _________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
31 Is internal training offered for staff on:   
Specimen collection transport and labeling? q	Yes   q	No    
Specimen receiving?  q	Yes   q	No    
Shipping infectious substances? q	Yes   q	No   
31a What topics are covered during training (e.g. specimen storage prior to collection, specimen packaging for transport, labeling, logging,  
processing, storage)? _________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
*Please provide additional information in the training table
32 General comments/notes regarding specimens:  ________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
Training
29 International Influenza Laboratory Capacity Review Tool
Specimen
Please indicate the number of specimens for each of the following and where they were shipped 











A (not-  
subtyped)
A(H1) A(H3) Australia Japan US UK China
Specimen Handling, Collecting, and Reporting
Virology Laboratory
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Virology Laboratory
1 Please indicate what influenza testing methods your virology laboratory currently performs. 
Virus Type
Current Direct Detection Methods











Low Pathogenic Avian 
Influenza
Other Avian Influenza
Other (please specify): ____________________________________________________________________________________________________  
 ________________________________________________________________________________________________________________________
International Influenza Laboratory Capacity Review Tool32
Virology Laboratory












 Other (non-influenza e.g. dengue, rotavirus) please specify: _____________________________________________________________________
 __________________________________________________________________________________________________________________________
 __________________________________________________________________________________________________________________________
 *If your laboratory performs virus isolation, please provide additional information in the table at the end of this section.
3 Does the laboratory assign strain designations to influenza viruses? q	Yes   q	No 
3a If yes, please describe which nomenclature is used (e.g. WHO criteria): __________________________________________________________  
 _________________________________________________________________________________________________________________________  
 _________________________________________________________________________________________________________________________  
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Virology Laboratory
4 If your laboratory is performing immunofluorescence testing please indicate kit and source.
  Kit and Source
 q	DFA  _______________________________________________________
 q	IFA  _______________________________________________________
5 Does the laboratory perform haemagglutination inhibition testing (HAI)? q	Yes   q	No 
5a If yes, does the laboratory use the WHO reagent kit? q	Yes   q	No
5b If yes, from which WHO Center? ____________________________________________________________________________________________
5c If yes, what is the laboratory’s main source of red blood cells: 
Animal ___________________________________________________________________________________________________________________  
Vendor / Source___________________________________________________________________________________________________________
6 Is there virology research conducted in the same laboratory as diagnostic testing?       q	Yes     q	No 
7 How much experience does the laboratory have performing influenza virus culture?  q	< 6 months q	6 - 12 months q	>12 months
Influenza Virus Culture 
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Virology Laboratory
8 Does the laboratory use cell culture, eggs, or both?   q	Cell Culture q	Eggs q	Both
Cell Line Source
QC Testing for Mycoplasma sp.  
performed (Y/N)
 Does the laboratory perform quality control testing for Mycoplasma on all cell lines? If yes, please check acceptable.   
q	Recommendation   q	Acceptable
9 Under normal operating conditions, how often are influenza specimens cultured during peak influenza season?
 q	Daily  q	Weekly q	Monthly q	Other (please specify) _______________________________________________
 Is the frequency of culturing specimens during peak influenza season acceptable? q	Recommendation   q	Acceptable
10 Approximately what percent of RT-PCR positive influenza specimens are cultured?  
q	Less then 10% q	10-20% q	20-30% q	30-40% q	40-50% q	Greater than 50%
11 What types of vessels are used for cell culture (check all that apply)?
 q	Flasks q	Tubes q	Shell vials q	Other (please specify) _________________________________________________
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Virology Laboratory
12 Is there a designated clean room for cell culture?       q	Yes     q	No
12a If no, where do you perform cell culture? ________________________________________________________________________________________
12b  If no, how do you prevent contamination? __________________________________________________________________________________________
13 Does the virology laboratory have a protocol to monitor contamination? q	Yes   q	No  
13a If yes, please describe: _______________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
14 In the virology laboratory, is there task-specific dedication and separation of:    
 Pipettes q	Yes     q	No     
 PPE q	Yes     q	No     
 Instrumentation q	Yes     q	No   
 Equipment q	Yes     q	No     
 Supplies q	Yes     q	No     
 Reagents q	Yes     q	No    
Contamination Control
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Virology Laboratory
15 Are there separate Biosafety Cabinets (BSCs) designated for influenza virology:    
 Cell culture q	Yes   q	No  
 Virus isolation q	Yes   q	No   
 Avian influenza (i.e. H5N1) q	Yes   q	No 
 Non-human influenza q	Yes   q	No   
16 Does the virology laboratory have a designated shelf or space for: 




17 Does the laboratory have written quality control virology procedures?      q	Yes   q	No   
17a Are the procedures updated regularly?  q	Yes   q	No   q	Do not Know/not sure
18 Does the laboratory quality control all reagents and standards used for virology procedures?      q	Yes   q	No   
19 Are critical reagents stored properly (antibiotics at @ 2ºC to 8ºC, BCS at -20ºC) for virology procedures? q	Yes   q	No   
Virology Quality Assurance
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Virology Laboratory
20 Is internal training offered for virology staff on virology methods?       q	Yes   q	No  




*Please provide additional information in the training table
21  General comments/notes regarding virology: ___________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
Virology Training
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Virus Isolation
Is the frequency of virus isolation activity acceptable? q	Recommendation   q	Acceptable 
Please estimate the number of strains your laboratory isolated within the past 2 years:
Date  
(mm/yyyy)
No. of Specimen No. of strains isolated
Collected Processed A (not- subtyped) A(H1) Pandemic A(H1) A(H3) B Unidentified Other (specify)
Virology Laboratory
Molecular Biology Laboratory
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Molecular Biology Laboratory
1 Please indicate what influenza testing methods your molecular biology laboratory currently performs. 
Virus Type















High Pathogenic Avian Influenza
Low Pathogenic Avian Influenza
Other Avian Influenza
 Other influenza viruses (please specify below): _________________________________________________________________________  
 
2 Approximately how many influenza specimens can the laboratory staff process per week by RT-PCR? 
q	Less than 5 q	5-10 q	10-15 q	15-20 q	Greater than 20 q	Other (please specify): __________________
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Molecular Biology Laboratory
2a Under normal operating conditions: 
Is your laboratory able to process all specimens within 1 week of receiving them?      q	Yes   q	No  
How many RT-PCR runs can the laboratory execute per day? _____________________________________________________________________  
How many specimens can be subtyped per day? ________________________________________________________________________________  
What percent of your specimens are positive for influenza A? ______________________________________________________________________
3 If the influenza laboratory is performing Real Time (RT-PCR) and Conventional PCR, which kit(s) and manufacturer are used? 
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
4 Please describe how each diagnostic RT-PCR run is set up (e.g. review SOP and describe plate set up, controls, etc.): ___________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
*Please provide Standard Operating Procedure for RT-PCR.
5 Does your molecular biology laboratory have a designated area for PCR set up?      q	Yes   q	No 
6 Does the laboratory have a uni-directional workflow (pre-amplification to post-amplification) for PCR?       q	Yes   q	No 
6a If no, why? __________________________________________________________________________________________________________________
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Molecular Biology Laboratory
7 Is there a designated area for handling RNA?       q	Yes   q	No 
8 What method does the laboratory currently use for RNA isolation / purification? ____________________________________________________
8a If a kit is employed to purify RNA, please identify which kit and the manufacturer. ____________________________________________________
9 What specific primers and probes are the laboratory using for influenza testing (e.g. source/manufacturer/other)? 
Seasonal/Novel Influenza _____________________________________________________________________________________________________  
Avian Influenza ______________________________________________________________________________________________________________  
Other _______________________________________________________________________________________________________________________
10 Does the laboratory use any system for internal quality control?      q	Yes   q	No 
10a If yes, please describe: _______________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
11 Are internal controls included in each test run?      q	Yes   q	No
11a If Yes, is the performance of these internal controls recorded and monitored over time?      q	Yes   q	No
11b If Yes, is there acceptance / rejection criteria?      q	Yes   q	No
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Molecular Biology Laboratory
12 Does the laboratory have a reliable source for RT-PCR reagents and supplies?       q	Yes   q	No 
12a If yes please identify the reagents (e.g. superscript, extractions kits, etc) and the sources (e.g. CDC, WHO, Manufacturer, etc.).
  Reagent Source
   ______________________  _______________________  
  ______________________  _______________________  
  ______________________  _______________________  
  ______________________  _______________________  
  ______________________  _______________________  
  ______________________  _______________________  
  ______________________  _______________________  
  ______________________  _______________________
12b Does the laboratory have difficulty procuring reagents?        q	Yes   q	No 
12c If yes, which reagents and why?  _______________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
13 Does the laboratory perform influenza sequencing?       q	Yes   q	No
13a If yes, where is the sequence data deposited? 
q	GISAID q	GenBank q	Other (please specify): _____________ q	Not reported
 Does the laboratory use an acceptable method for reporting sequence data? q	Recommendation   q	Acceptable
Sequencing 
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Molecular Biology Laboratory
14 Does the laboratory perform influenza phylogenetic analyses? q	Yes   q	No 
14a If yes, please explain: _________________________________________________________________________________________________________
 
15 Does the molecular biology laboratory have a protocol to monitor contamination? q	Yes   q	No
15a If Yes, please describe: _______________________________________________________________________________________________________
16 Is there a designated area for handling post-PCR amplified product?       q	Yes   q	No 
17 In the molecular biology laboratory, is there task-specific dedication and separation of:    
 Pipettes q	Yes     q	No Equipment q	Yes     q	No
 PPE q	Yes     q	No Supplies q	Yes     q	No
 Instrumentation q	Yes     q	No Reagents q	Yes     q	No
18 Are any of the following dedicated for pre-PCR use only?
 q	Pipettes q	Personal protective equipment (PPE) q	Supplies q	Reagents q	Centrifuges  
 q	Other (please specify) ____________________________________________________
Storage and Contamination Control 
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Molecular Biology Laboratory
19 Does the molecular biology laboratory have a designated shelf or space for:  




20 Are critical reagents (i.e. enzymes) stored in frost free freezers?      q	Yes   q	No
20a If yes, is the automatic defrost disabled?      q	Yes   q	No
21 Does the laboratory have written quality control molecular procedures? q	Yes   q	No
21a If yes, are the procedures updated regularly? q	Yes   q	No
22 Does the laboratory quality control all reagents and standards used for molecular procedures? q	Yes   q	No
23 Are critical reagents stored properly (enzymes @ -20ºC, buffers @ 2ºC to 8ºC, etc.) for molecular procedures?  
q	Yes   q	No 
Molecular Quality Assurance 
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Molecular Biology Training
24 Is internal training offered for molecular biology staff on laboratory methods?  q	Yes   q	No
24a What topics are covered during training?  (e.g. PCR, Nucleic Acid Extraction): _______________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
*Please provide additional information in the training table
25 General comments/notes regarding molecular biology:  __________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
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Laboratory Biosafety and Safety
1 Does the facility have a designated safety team? q	Yes q	No
1a If yes, does the influenza laboratory have a member?  q	Yes q	No
1b Is there a safety officer for the influenza laboratory?  q	Yes q	No
2 Does the laboratory have a safety manual? q	Yes q	No
2a If yes, is it easily accessible to all laboratory staff? q	Yes q	No
2b If yes, is it located in the laboratory?  q	Yes q	No
2c If yes, is it reviewed annually? q	Yes q	No
2d If yes, is it edited/updated to reflect changes?  q	Yes q	No
2e If yes, are laboratory staff required to review  
and sign indicating their understanding and  
acknowledgment of safety procedures? q	Yes q	No
3 What source does the laboratory reference for its biosafety guidelines? 
q	Biosafety in Microbiological and Biomedical Laboratories 
q	WHO 
q	National Regulations 
q	Other (please describe) ______________________________________________________
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4 Are staff forbidden from doing the following:
Yes No
Wearing PPE outside of the laboratory (i.e. 
coffee room, canteens, etc)?
Wearing open-toed footwear in the laboratory?
Eating, drinking, smoking, or applying  
cosmetics in the laboratory?
Storing food or drinks in the laboratory  
working areas?
Mouth pipetting?







 Other (please specify): ________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
5a If no to any of the above, why? ________________________________________________________________________________________________
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6 Is the available PPE appropriate for specific tasks? q	Yes q	No
6a If no, why? ________________________________________________________________________________________________________________________
7 Are powder free gloves worn for all manipulations of specimens, organisms, and reagents?      q	Yes   q	No
7a If no, are they worn for: 
q	Designated procedures only q	Technician discretion
8 What type of laboratory coats are available for staff (please check all that apply)?
 q	Cloth q	Impermeable q	Cuffed Sleeves q	Disposable q	Properly sized 
 q	Other (please describe)___________________________________________________
9 How are cloth lab coats cleaned?
 q	At the Laboratory q	At home q	Commercially q	Not Applicable  
 q	Other (please describe)___________________________________________________ 
10 Is there a hand washing station inside the influenza laboratory? q	Yes q	No
10a If not, where is it located?  __________________________________________________________________________________________________________
10b If there is not a hand washing station, what is the alternate method? _____________________________________________________________________
10c Is soap available for hand washing?  q	Yes   q	No
10d Are towels or paper available for hand-drying?  q	Yes   q	No
 Is the hand washing set up in the laboratory acceptable? q	Recommendation   q	Acceptable
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11 Is the hand-wash station a hands-free set-up (e.g. operated using foot-pedals)? q	Yes q	No
12 Is there an eye-wash station in the laboratory? q	Yes q	No
12a If no, where is it located?  ___________________________________________________________________________________________________________
12b Is the eye-wash station readlily accessible? q	Yes q	No
13 Is there a shower in the laboratory? q	Yes q	No
13a If no, where is it located?  ___________________________________________________________________________________________________________
13b Is the shower station readlily accessible? q	Yes q	No
14 Do laboratory staff receive any safety training (please check all that apply)?
 q	Chemical q	Fire q	Evacuation q	Natural Disasters q	Other (please describe) ___________________________
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15 Please list required and optional vaccines listed in the laboratory vaccination policy: 
Vaccines Required Optional
Included in Country Immunization 
Program (i.e. Vaccine Preventable 
Diseases)
16 What is the current biosafety level of the facility (please check all that apply)?
  Percentage of Laboratory Space Availability of Laboratory Space 
 q BSL-1 _______________________________   _______________________________  
q BSL-2 _______________________________   _______________________________  
q BSL-3 _______________________________   _______________________________
Laboratory Biosafety Level 
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17 If the facility operates at BSL-2, are the following BSL-2 practices maintained, as defined by Biosafety in Microbiological and  
Biomedical Laboratories: 
 Restricted access to laboratory?  q	Yes q	No
 Lab personnel provided medical surveillance and immunizations? q	Yes q	No
 Lab personnel  trained on how to handle pathogenic agents?  q	Yes q	No
 Incidents resulting in exposure are immediately evaluated and  
treated according to biosafety manual procedures?  q	Yes q	No
 PPE is used when handling infectious material?    q	Yes q	No
 BSCs, or other physical containment units, are used?   q	Yes q	No
 BSCs are regularly maintained?    q	Yes q	No
 Designated containers are used for infectious materials?    q	Yes q	No
 Equipment decontaminated before repair/maintenance/removal?    q	Yes q	No
17a If no to any of the above, please describe:  ____________________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________________
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18 If the facility operates at BSL-3, are the following BSL-3 practices maintained, as defined by the Biosafety in Microbiological and  
Biomedical Laboratories: 
 Controlled access to laboratory? q	Yes q	No
 Lab personnel provided medical surveillance and immunizations? q	Yes q	No
 Lab personnel  trained on how to handle pathogenic agents? q	Yes q	No
 Are all procedures involving infectious material conducted  
within BCSs?  q	Yes q	No
 Are BSCs regularly maintained?  q	Yes q	No
 Laboratory specific biosafety level 3 manuals are available? q	Yes q	No
 Incidents resulting in exposure are immediately evaluated and  
treated according to biosafety manual procedures? q	Yes q	No
 PPE is used when handling infectious material?  q	Yes q	No
 Autoclave for waste disposal (e.g. 2 door)?  q	Yes q	No
 Designated containers are used for infectious materials?   q	Yes q	No
 Equipment decontaminated before repair/maintenance/removal?  q	Yes q	No
 Is there directional airflow?   q	Yes q	No
 Were facility design, operational parameters, and procedures  
verified and documented prior to operation?   q	Yes q	No
 Is the facility re-verified and documented at least annually?    q	Yes q	No
18a If no to any of the above, please describe:  ____________________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________________
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19 If handling H5, is there a respirator fit program? q	Yes     q	No     q	NA, don’t handle H5
20 Are PAPRs available for staff that cannot wear N95 respirators?  ___________________________________________________________________
q	Yes     q	No
21 Does the laboratory use BSL-3 practices in a BSL-2 laboratory? q	Yes q	No
21a If Yes, please describe: _____________________________________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________________
21b If the laboratory uses BSL-3 practices in a BSL-2 laboratory, are the practices acceptable? ___________________________________________
q	Recommendation   q	Acceptable
22 Does the laboratory have written clean-up instructions for spills?  q	Yes   q	No
22a If yes, are they posted on the walls in the laboratory?  q	Yes   q	No
23 What chemicals are routinely used for surface decontamination?
Surface decontaminant Used? (Y/N) Concentration? Length in circulation?
Ethanol
Bleach
 Other (please specify): ________________________________________________________________________________________________________
Chemical Safety
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24 Do you disinfect the following on a monthly basis:
 Centrifuges?  q	Yes     q	No   Incubators?  q	Yes     q	No
25 Are there metal cabinets for flammable chemicals?  q	Yes   q	No
26 Are volumes of acids and bases greater than one liter stored in the laboratory?   q	Yes   q	No
26a If yes, are they stored separately?   q	Yes   q	No 
27 Does the laboratory have a written standard operating procedure for proper biohazard disposal? q	Yes   q	No
28 What treatments are used for biohazard waste disposal?




Burial with no pre-treatment
Sharps container
Chemical disinfection
 Other (please specify): ________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
Biohazard Disposal 
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28a If the influenza laboratory utilizes autoclaves, is the number of autoclaves sufficient for the amount of biohazardous waste generated? 
q	Yes   q	No
29 Do you always use temperature strips for sterilization? q	Yes   q	No
30 Is internal training offered for staff on biosafety methods?  q	Yes   q	No
30a What topics are covered during training? _____________________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________________ 
*Please provide additional information in the training table
31 General comments/notes regarding safety: _____________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
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Quality Assurance/Quality Control
1 Does the laboratory have written standard operating procedures for (check all that apply):
 q	All assays q	Sterilization/disinfection procedures q	Other (please describe) ______________________________________  
 If applicable, please provide the laboratory’s sterilization / disinfection procedures.
2 Are funds for reagents part of your laboratory’s annual budget? q	Yes   q	No
3 Does the laboratory keep records of deliveries of reagents and supplies? q	Yes   q	No
4 Does the laboratory keep an inventory of stock? q	Yes   q	No
5 Are quantities of reagents and materials regularly monitored so that there is a warning if stocks become low? q	Yes   q	No
6 Does the laboratory have a maximum stock level for reagents and consumables?  q	Yes   q	No
7 Who determines how much stock to order? ___________________________________________________________________________________________
Inventory Control 
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8 On average, how long does it take from time of ordering to when supplies are available for use?  ____________________________________________
8a Please list any supplies where there are particularly long delays and how long these delays can be. ____________________________________  
 ____________________________________________________________________________________________________________________________
9 Does the laboratory have difficulty maintaining inventory of supplies and reagents from outside of the country?  q	Yes   q	No
10 Does the laboratory have difficulty maintaining inventory of supplies and reagents from inside of the country?  q	Yes   q	No
11 How do reagents and supplies arrive at the laboratory? _________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________________ 
 __________________________________________________________________________________________________________________________________
12 Please indicate if your laboratory does the following inventory control procedures:
Always Sometimes Never
Regularly check the expiration dates of your reagents?
Write the opening date of the reagents on the  
containers and kits?
Perform yearly inventories of your stock?
Use expired products and reagents?
Exchange reagents with other labs in case of shortage?
Reuse consumables?
 Is the frequency of the exchange of reagents acceptable? q	Recommendation   q	Acceptable
 Is the frequency of reusing of consumable acceptable? q	Recommendation   q	Acceptable
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Quality Assurance/Quality Control
13 Please indicate the following equipment quality assurance procedures your laboratory performs (check all the apply): 
Back-up equipment is  
available in case of  
equipment failure
Regularly monitored  
temperature readings
Temperature monitored with 
certified thermometers  
(e.g. National Institute of  
Standards & Technology)




 Other (please specify): ________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
14 Does the laboratory have a written preventive maintenance plan and schedule for equipment?  q	Yes   q	No
15 Does the laboratory keep preventive maintenance records for equipment?  q	Yes   q	No
16 Are all automated laboratory equipment calibrated at least annually?  q	Yes   q	No
17 Are all non-automated laboratory equipment (pipettes, heat blocks, etc.) calibrated at least annually?  q	Yes   q	No
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Quality Assurance/Quality Control
18 What volume disposable tips does the laboratory currently use? ___________________________________________________________________
 ____________________________________________________________________________________________________________________________
18a Do the tips used in the laboratory fit the pipettes properly?         q	Yes   q	No
19 Does your laboratory maintain up to date training records for all personnel ? q	Yes   q	No
20 General comments/notes regarding quality assurance: __________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________
Equipment
64 International Influenza Laboratory Capacity Review Tool
Equipment
Please indicate which equipment your laboratory uses in the corresponding section.  
Please included additional information as requested. 










staff available  













































































































Is the maintenance of centrifuges acceptable? q	Recommendation   q	Acceptable
Are the bucket lids for centrifuges acceptable? q	Recommendation   q	Acceptable
Is the maintenance of autoclaves acceptable? q	Recommendation   q	Acceptable
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available to fix 
equipment? (Y/N)
Equipment shared 
with other labs? 
(Y/N)
Regularly check 
the Kohler  





Upright for tissue culture
Immunofluorescence







Is the maintenance of microscopes acceptable? q	Recommendation   q	Acceptable
Is the calibration of pipettes acceptable? q	Recommendation   q	Acceptable
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For eggs  
(non-CO2)
CO2
Are the maintenance agreements on  RT-PCR machines acceptable? q	Recommendation   q	Acceptable
Is the maintenance of BSCs acceptable? q	Recommendation   q	Acceptable
Are all BSCs certified annually? q	Recommendation   q	Acceptable
Is the maintenance of incubators acceptable? q	Recommendation   q	Acceptable
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staff available  
to fix equipment? (Y/N)
Equipment shared with 
other labs? (Y/N)
Connected to the  
internet? (Y/N)
If applicable, how fast 













68 International Influenza Laboratory Capacity Review Tool
Equipment








staff available  
to fix equipment? 
(Y/N)
Equipment shared 
with other labs? (Y/N)
Dedicated to  
Virology, Molecular 
biology, RNA only,  
post PCR, other?
Miscellaneous:
Freezers ( -20ºC to -40ºC)
Freezers ( -70ºC to -80ºC)
 Liquid nitrogen
Refrigerators (2ºC to 8ºC)
PCR hood with UV 
Wet Ice machine/ access 
Water Bath
Vortex
24-well cooler racks x 2





Is the maintenance of refrigerators and freezers acceptable? q	Recommendation   q	Acceptable
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staff available  
to fix equipment? 
(Y/N)
Equipment shared 






















































































































































































































































































































Specimen Handling,  
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Capacity Report Template
1.0  Purpose & Objectives
 The purpose of this site visit was to document the capacities of laboratory name.  The objectives were to:
1.1 Meet laboratory staff and key stakeholders, and tour the laboratory. 
1.2 Complete the International Influenza Laboratory Capacity Review.
1.3 Provide a report describing the status of laboratory capacity with recommendations for improvement based on data collected through the tool and ob-
servation of laboratory practices; 
1.4 Provide training in… and/or troubleshooting as needed.
1.5 Etc. List others objectives if applicable e.g. Report on recommendations the laboratory has addressed since their last assessment.
2.0  Background 
 Please provide a short narrative paragraph about the laboratory which addresses:
Name of Laboratory:
Address:
Laboratory Director: Title Name Surname
Dates of Assessment: Month day to Month day, 20xx. E.g. July 29 to August 2, 2011
Reviewer/s: Name Surname, qualifications (e.g. MT(ASCP)), position & institution, email address, telephone number.
Project Officer: Name Surname
NIC Status: Designated 20xx or Not designated
Influenza Laboratory Capacity Report
Laboratory Name
Country 20xx
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Capacity Report Template
• In which year was the laboratory established?  
• Does it have any affiliations? (e.g. Ministry of Health, a University, USAID, Pasteur Institute etc.)
• What is the laboratory’s primary function? (e.g. Diagnostic, Research, etc.)
• Does it provide other surveillance and/or diagnostic testing besides influenza testing?  (e.g. HIV)
• Is it a designated NIC?  If yes, in which year was it designated? If not, have they applied for NIC status or are they aspiring to become an NIC?
• Any other pertinent details (e.g. the laboratory has a new Director since month, year… The laboratory was relocated to … in month, year.  
The laboratory was previously called … and changed its name in year to…)
3.0 Staff and Stakeholders  
 List the laboratory staff and key stakeholders with whom you met such as, the Laboratory Director, Ministry of Health representatives, CDC in-country 
contact/s, etc.  Include titles (e.g. Ms, Dr, Prof), full names, positions and affiliated institutions.  Please include contact information (e.g. email, telephone num-
bers) for staff or stakeholders not already captured in the tool. 
4.0 General Findings
 Please describe the laboratory’s capacity by report section including their strengths and limitations. If this is a repeat assessment, please specify any recom-
mendations from the previous assessment which have been addressed, and how, during the intervening period. For any question-specific comments, please 
note the relevant question number.
4.1 General Laboratory
4.2  Specimen Handling, Collection and Reporting
4.3  Virology Laboratory
4.4  Molecular Biology Laboratory
Name Position Institution/Affiliation Contact
Mr. Name Surname Epidemiologist WHO email &/or phone
Dr. Name Surname Veterinarian CDC-city email &/or phone
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Capacity Report Template
4.5  Laboratory Safety and Biosafety




 Please list the laboratory’s strengths and/or improvements in capacity, for example: 
5.1 Since month, year the laboratory has commenced real-time PCR for detecting and sub-typing influenza viruses including seasonal, 2009 A/H1N1 and H5. 
 Include in the list any positive responses to the gold-star questions, for example, 
5.2 Laboratory uses eggs and cell culture.
6.0 Recommendations
 If conducting a re-assessment, please include any previous recommendations made that have not been met. 
6.1 Laboratory Recommendations
 Please list recommendations for the laboratory for example:
6.1.1 The NIC should store all PCR reagents such as AgPath/Invitrogen kits, primers & probes and PCR control material in NON frost-free freezers (or frost-free 
freezers where the frost-free function has been disabled).
6.2  Training Recommendations
 Please list recommendations for training here:
6.2.1 Train staff on procedures for handling unsubtypable influenza A specimens (e.g. re-testing the specimen to confirm original result, notifying and shipping  
specimens to a WHO-CC).
7.0 Procurement List
 Please list recommended equipment or supplies for the laboratory in order of importance, for example: 
7.1 PCR workstation (PCR dead-air box) for loading RNA into 96 well PCR plates.
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Capacity Report Template
8.0  Acknowledgements
 Please include any acknowledgements if applicable.
9.0  Appendices
 Attach algorithms, a diagram of the laboratory, SOPs, etc. here. Any photographs should be sent to APHL and CDC along with relevant photo waiver forms (see 
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AC: air-conditioning  
AFR:  WHO Africa Region  
AMR:  WHO Region of the Americas  
APHL: Association of Public Health Laboratories  
BSC:  biosafety cabinet  
BSL:  biosafety level  
CDC:  Centers for Disease Control and  
Prevention  
CO2:  carbon dioxide  
DFA:  direct immunofluorescent antibody test  
ELISA:  enzyme-linked immunosorbent assay   
EMR:  WHO Eastern-Mediterranean Region  
EUR:  WHO European Region  
GI:  gastro-intestinal  
GISAID:  Global Initiative on Sharing Avian  
Influenza Data  
HA:  haemagglutination test  
HAI:  haemagglutination inhibition test  
HIV:  human immunodeficiency virus  
IATA:  International Air Transport Association  
ID:  identification  
IFA:  indirect immunofluorescent  
antibody test  
IHR:  International Health Regulations  
NGO:  non-government organization  
NIC:  National Influenza Centre  
NIST:  National Institute of Standards and  
Technology  
PAHO:  Pan American Health Organization  
PAPR:  powered air purifying respirator   
PATH:  Program for Appropriate Technology  
in Health (a Seattle-based NGO)  
PCR:  polymerase chain reaction  
PPE:  personal protective equipment  
QA:  quality assurance  
QC:  quality control  
RNA:  ribonucleic acid  
RT-PCR:  real-time polymerase chain reaction  
SEAR:  WHO South-East Asia Region  
SOP:  standard operating procedure  
STD:  sexually transmitted disease  
TB:  tuberculosis  
UPS:  uninterruptable power supply  
USAID:  United States Agency for  
International Development   
UV:  ultraviolet  
v: volts  
VTM:  viral transport medium  
w:  watts  
WHO:  World Health Organisation  
WHO CC: World Health Organisation  
Collaborating Centre  
WPR:  WHO Western Pacific Region
Acronyms:
Appendix A
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Databases and Information Systems 
http://www.who.int/csr/resources/databases/ 
en/index.html











African Centre for Integrated Laboratory Training 
(ACILT) — Training sub-Saharan Africa on Biosafety
http://www.cdc.gov/globalaids/resources/ 
laboratory/Lab-Training-Center.html
International Organization of Standardization
http://www.iso.org
WHO External Quality Assessment Project for the 
Detection of Subtype Influenza A Viruses by PCR
http://www.who.int/influenza/resources/ 
documents/EQA_infuenza_A_PCR/eqa20070706.pdf






Pandemic Influenza Preparedness Framework  




Pandemic Influenza Preparedness Framework – 
Questions and Answers 
http://www.who.int/influenza/pip/PIP_FQA_
Nov_2011.pdf
WHO Global Influenza Surveillance Network: 
Manual for the Laboratory Diagnosis and  
Virologic Surveillance of Influenza 
http://whqlibdoc.who.int/publica-
tions/2011/9789241548090_eng.pdf













85 International Influenza Laboratory Capacity Review Tool
Appendix B
• Invitrogen Catalog #11732-020, SuperScript™III Platinum®  
One-Step Quantitative RT-PCR Kits
• Ambion Catalog #AM1005, AgPath-ID One-Step RT-PCR Kit    
• Positive control viral RNAs (H3N2, H5N1 and Human) 
• Forward and reverse primers (40μM) (FluA, H1, H3, H5, FluB, RNP)
• Dual-labeled probes (10μM) (FluA, H1, H3, H5, FluB, RNP)
• 0.2ml PCR reaction tube strips or plates 
• Optical strip caps  
• Powder-free gloves (small, medium, large)
• Sterile 1.4 ml microcentrifuge tubes  100/pk x 1
• Lint free clean wipes
• Aluminum foil
• Diposable lab coats (Small, Medium, Large)
• Cloth lab coats (Small, Medium, Large)
• Bleach or RNase AwayTM
• RNA extraction kit : Qiagen viral RNA kit
• 100% reagent grade ethanol
• Water (nuclease free)
• Calculators
• Powder-Free Gloves (Small, Medium, Large)
• Lab Notebooks
• Lint Free Clean Wipes
• Sterile Nuclease Free Filtered Pipette Tips
• Serologic Pipet Aid (Example:Drummond)
Suggested Reagents and Supplies 
The Association of Public Health Laboratories (APHL) is a national non-profit organization 
dedicated to working with members to strengthen governmental laboratories that perform 
testing of public health significance. By promoting effective programs and public policy, 
APHL strives to provide member laboratories with the resources and infrastructure needed 
to protect the health of US residents and to prevent and control disease globally.
This APHL/CDC International Influenza Laboratory Capacity Tool was fully funded by  
Cooperative Agreement # U60HM000803 from CDC and/or Assistant Secretary for  
Preparedness and Response.  Its contents are solely the responsibility of the authors and  
do not necessarily represent the official views of CDC and/or Assistant Secretary for  
Preparedness and Response or APHL.

